Ovarian Cancer Clinical Trial
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
Summary
To compare the efficacy of olaparib in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian cancer
Eligibility Criteria
Inclusion Criteria:
Diagnosed with serous ovarian cancer
Patients who have received no more than 3 previous platinum containing treatments and were progression free for at least 6 months following the end of the last platinum treatment
At least one lesion that is suitable for accurate repeated measurements
Exclusion Criteria:
Patients receiving any systemic anticancer chemotherapy, radiotherapy (except palliative) within two weeks from the last dose prior to study treatment
Hypersensitivity to pre medications required for treatment with paclitaxel/carboplatin
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 41 Locations for this study
West Hollywood California, 90048, United States
Orlando Florida, 32806, United States
Boston Massachusetts, 02215, United States
New York New York, 10016, United States
Portland Oregon, 97227, United States
Parkville , 3050, Australia
Randwick , 2031, Australia
Brussels , 1090, Belgium
Leuven , 3000, Belgium
Namur , 5000, Belgium
Wilrijk , 2610, Belgium
Vancouver British Columbia, V5Z 4, Canada
Hamilton Ontario, L8V 5, Canada
Toronto Ontario, M4N 3, Canada
Quebec , G1R 2, Canada
Brno , 656 5, Czechia
Hradec Kralove , 500 0, Czechia
Olomouc , 775 2, Czechia
Essen , 45147, Germany
Frankfurt , 60590, Germany
Hamburg , 20246, Germany
München , 81675, Germany
Solingen , 42653, Germany
Genova , 16132, Italy
Milan , 20141, Italy
Monza , 20052, Italy
Torino , 10126, Italy
Chuo-ku , 104-0, Japan
Fukuoka-shi , 811-1, Japan
Matsuyama-shi , 791-0, Japan
Morioka-shi , 028-3, Japan
Shinjuku-ku , 160-8, Japan
Yamagata-shi , 990-9, Japan
Amsterdam , 1066 , Netherlands
Nijmegen , 6525 , Netherlands
Rotterdam , 3015 , Netherlands
Lima , LIMA , Peru
Lima , LIMA , Peru
Madrid , 08035, Spain
Valencia , 46010, Spain
Birmingham , B18 7, United Kingdom
Edinburgh , EH4 2, United Kingdom
How clear is this clinincal trial information?